
Genetic Technologies Limited GENE
Annual report 2022
added 08-30-2022
Genetic Technologies Limited ROE Ratio 2011-2026 | GENE
Annual ROE Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.4 | -32.87 | -44.99 | -362.78 | -115.96 | -79.44 | -71.18 | -46.47 | -554.04 | -161.48 | -36.71 | 13.35 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.35 | -554.04 | -128.0 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
22.45 | $ 115.62 | 0.06 % | $ 35.1 B | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 1.65 | -1.2 % | $ 2.19 M | ||
|
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 24.98 | 2.13 % | $ 694 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 21.85 | 2.92 % | $ 1.16 B | ||
|
Illumina
ILMN
|
-51.54 | $ 128.52 | 0.5 % | $ 20.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 15.6 | -4.35 % | $ 472 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 84.11 | -0.26 % | $ 5.68 B | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 171.23 | 0.86 % | $ 8.49 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 421.37 | 2.64 % | $ 12.2 B | ||
|
Guardant Health
GH
|
419.18 | $ 88.5 | -0.46 % | $ 11.1 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.54 | 0.25 % | $ 20 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Personalis
PSNL
|
-40.05 | $ 5.96 | -2.3 % | $ 353 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 1.93 | -2.08 % | $ 8.54 M | ||
|
Senseonics Holdings
SENS
|
-113.21 | $ 7.27 | 3.12 % | $ 303 M | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
4.64 | $ 52.75 | 0.06 % | $ 2.68 B | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.45 | -0.94 % | $ 2.05 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.18 | 1.87 % | $ 5.01 M | ||
|
National Research Corporation
NRC
|
82.92 | $ 17.11 | -0.7 % | $ 383 M | ||
|
Thermo Fisher Scientific
TMO
|
12.55 | $ 468.04 | -0.36 % | $ 176 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 103.21 | 1.02 % | $ 8.51 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 263.43 | -0.12 % | $ 21.9 B | ||
|
Trinity Biotech plc
TRIB
|
287.88 | $ 0.64 | -0.82 % | $ 61.9 M | ||
|
Celcuity
CELC
|
-176.06 | $ 125.68 | 3.84 % | $ 5.88 B | ||
|
Twist Bioscience Corporation
TWST
|
-16.42 | $ 61.0 | 0.1 % | $ 3.65 B | ||
|
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
-12.91 | $ 8.61 | 3.86 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
-99.43 | $ 4.83 | 1.05 % | $ 447 M | ||
|
Natera
NTRA
|
-77.62 | $ 204.39 | 0.31 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.63 | 0.21 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M |